Akouos, Inc. (AKUS) Financial Statements (2024 and earlier)

Company Profile

Business Address 645 SUMMER STREET, SUITE 200
BOSTON, MA 02210
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2022
MRQ
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 232,452,000308,010,000
Cash and cash equivalents 121,907,00068,932,000
Short-term investments 110,545,000239,078,000
Other undisclosed current assets 3,711,0002,626,000
Total current assets: 236,163,000310,636,000
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization 200,000300,000
Operating lease, right-of-use asset 20,341,0005,964,000
Restricted cash and investments 2,448,0001,317,000
Other noncurrent assets  45,000
Other undisclosed noncurrent assets 19,603,00015,088,000
Total noncurrent assets: 42,592,00022,714,000
TOTAL ASSETS: 278,755,000333,350,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 5,584,0005,081,000
Employee-related liabilities3,234,0002,438,000
Accounts payable 1,280,000895,000
Accrued liabilities 1,070,0001,748,000
Debt  188,000
Other undisclosed current liabilities 11,217,0005,440,000
Total current liabilities: 16,801,00010,709,000
Noncurrent Liabilities
Long-term debt and lease obligation: 28,304,00012,027,000
Operating lease, liability 28,304,00012,027,000
Other undisclosed noncurrent liabilities (28,304,000)(12,027,000)
Total noncurrent liabilities: 28,304,00012,027,000
Total liabilities: 45,105,00022,736,000
Equity
Equity, attributable to parent 233,650,000310,614,000
Common stock 3,0003,000
Additional paid in capital 402,244,000392,322,000
Accumulated other comprehensive income (loss) (202,000)13,000
Accumulated deficit (168,395,000)(81,724,000)
Total equity: 233,650,000310,614,000
TOTAL LIABILITIES AND EQUITY: 278,755,000333,350,000

Income Statement (P&L) (USD)

9/30/2022
TTM
12/31/2021
12/31/2020
Operating expenses (86,821,000)(48,880,000)
Operating loss: (86,821,000)(48,880,000)
Nonoperating income 150,000280,000
Other nonoperating expense (1,722,000)(287,000)
Interest and debt expense (1,000)(6,000)
Loss from continuing operations: (86,672,000)(48,606,000)
Loss before gain (loss) on sale of properties:(86,672,000)(48,606,000)
Net loss: (86,672,000)(48,606,000)
Other undisclosed net income attributable to parent 1,0006,000
Net loss available to common stockholders, diluted: (86,671,000)(48,600,000)

Comprehensive Income (USD)

9/30/2022
TTM
12/31/2021
12/31/2020
Net loss: (86,672,000)(48,606,000)
Comprehensive loss: (86,672,000)(48,606,000)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (214,000)19,000
Comprehensive loss, net of tax, attributable to parent: (86,886,000)(48,587,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: